ROCKWELL MEDICAL, INC. Available-for-sale Securities
ROCKWELL MEDICAL, INC. (RMTI) had Available-for-sale Securities of $14.55 million as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2019-11-12
- 2019-09-30: Available-for-sale Securities $14.55M.
- 2019-06-30: Available-for-sale Securities $13.80M.
- 2019-03-31: Available-for-sale Securities $6.87M.
- 2018-12-31: Available-for-sale Securities $10.80M.
| Period end | Available-for-sale Securities | Available-for-sale Securities as first filed |
|---|---|---|
| 2019-09-30 | $14.55M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $13.80M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $6.87M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $10.80M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $24.68M 10-K · filed 2019-03-18 | $51.92M 10-K · filed 2018-03-15 |
| 2016-12-31 | $24.49M 10-K · filed 2018-03-15 | |
| 2015-12-31 | $1.47M 10-K · filed 2017-03-15 | $1.47M 10-K · filed 2016-02-29 |
| 2014-12-31 | $4.98M 10-K · filed 2016-02-29 | |
| 2012-12-31 | $14.04M 10-K · filed 2014-03-07 | |
| 2011-12-31 | $2.00M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |